Detection of G-quadruplex DNA in mammalian cells.
Henderson A, Wu Y, Huang YC, Chavez EA, Platt J, Johnson FB, Brosh RM, Sen D, Lansdorp PM. · 2014
Read Detection of G-quadruplex DNA in mammalian cells. by Henderson A, Wu Y, Huang YC, Chavez EA, Platt J, Johnson FB, Brosh RM, Sen D, Lansdorp PM. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3902944.txt.
Introduction
Alexander Henderson and a team of co-authors build a DNA probe tool in Nucleic Acids Research, with the record dated 2014. Guanine-rich DNA can fold into four-stranded knots called G-quadruplexes. Such knots are tied to gene control and other cell jobs, yet tools to see them inside living cells were scarce.
The team made mouse antibodies that grip distinct knot shapes. One antibody lit up cell nuclei in most human and mouse cells. Drugs that lock knots in place raised the glow. Cells missing a knot-unwinding enzyme glowed stronger still, as if knots piled up without it. The results back the claim that these knots truly form in mammalian cells, and give labs a tool to study them.
Catalog record
| CREATOR | Henderson A, Wu Y, Huang YC, Chavez EA, Platt J, Johnson FB, Brosh RM, Sen D, Lansdorp PM. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Detection of G-quadruplex DNA in mammalian cells By Alexander Henderson, Yuliang Wu, Yu Chuan Huang, Elizabeth A Chavez, Jesse Platt, F Brad Johnson, Robert M Brosh, Dipankar Sen, Peter M Lansdorp Published in: Nucleic Acids Research DOI: 10.1093/nar/gkt957 ABSTRACT Abstract It has been proposed that guanine-rich DNA forms four-stranded structures in vivo called G-quadruplexes or G4 DNA. G4 DNA has been implicated in several biological processes, but tools to study G4 DNA structures in cells are limited. Here we report the development of novel murine monoclonal antibodies specific for different G4 DNA structures. We show that one of these antibodies designated 1H6 exhibits strong nuclear staining in most human and murine cells. Staining intensity increased on treatment of cells with agents that stabilize G4 DNA and, strikingly, cells deficient in FANCJ, a G4 DNA-specific helicase, showed stronger nuclear staining than controls. Our data strongly support the existence of G4 DNA structures in mammalian cells and indicate that the abundance of such structures is increased in the absence of FANCJ. We conclude that monoclonal antibody 1H6 is a valuable tool for further studies on the role of G4 DNA in cell and molecular biology. INTRODUCTION Single-stranded guanine (G)-rich DNA can form stable secondary structures in vitro called G-quadruplex (G4) DNA (1,2). G4 DNA is generated through the association of four guanines bound through Hoogsteen base pairing and characterized by variable stacks of guanine quartet planes, strand orientation, glycosidic bond angles and stabilizing cations (3). Putative G4-forming sequences are proposed to form functionally relevant G4 DNA structures throughout the genome including immunoglobulin switch regions, promoter sequences, rDNA and telomeric repeats (4,5). However, in theory, G4 DNA can arise anywhere in the genome where sufficiently long stretches of single-stranded G-rich DNA are exposed during replication, transcription or recombination (6). Detailed in vitro chemical analysis of quadruplex-forming oligonucleotides has revealed the existence of a plethora of dynamic quadruplex structures with varying stabilities (3,7–12). The structural polymorphism of G4 DNA could make these structures valuable molecular targets to study biological processes and for possible therapeutic intervention (3). Interest in G4 DNA has been increased by the discovery that stabilized quadruplex structures negatively affect enzyme-catalyzed elongation of telomeric sequences in vitro (13). Given that up to 90% of all cancers rely on the activity of telomerase for continued growth, control of telomerase-mediated telomere elongation through G4 DNA stabilization is perceived as having therapeutic potential. The potential to inhibit telomerase for cancer therapy has spurred the development of small molecules that target and stabilize G4 DNA. Treatment of various cancer cell lines with such ligands was found to result in telomere shortening and senescence, supporting that stabilization of G4 DNA structures can perturb telomere homeostasis and potentially suppress tumor growth (14). Moreover, a number of human genetic diseases are characterized by telomere defects, and it has been proposed that G-quadruplex structures forming either at the 3′ end of telomeres or during telomere replication play a role in such diseases (15,16). Despite these postulated connections between G4 DNA and human disease, there is to date limited direct evidence for the existence of G4 DNA in human cells. Here we report the development and characterization of novel monoclonal antibodies specific for distinct structural variants of G4 DNA. Immunofluorescence microscopy studies using one of these, designated 1H6, showed nuclear staining in most human cells, which was suppressed by the addition of soluble G4 DNA and abolished with prior treatment with DNase. Treatment of cells with G-quadruplex stabilizing small molecules 5,10,15,20-tetra(N-methyl-4-pyridyl)–porphyrin (TMPyP4) or telomestatin (TMS) increased the number and intensity of the nuclear staining by 1H6. Furthermore, vertebrate cells deficient for the G4 resolving helicase FANCJ that were exposed to TMS showed stronger 1H6 nuclear staining than controls, supporting the notion that G4 DNA is enriched as a consequence of a genetic deficiency. Taken together, our results support the presence of abundant G4 DNA in most mammalian cells. We propose that 1H6 and the other monoclonal antibodies against G4 structures described in this report are valuable analytical tools for further studies on the biological and therapeutic role of G4 DNA in vivo. MATERIALS AND METHODS Polyacrylamide gel analysis and circular dichroism studies G4 DNA secondary structure was assessed by native gel electrophoresis with a 12–15% polyacrylamide gel containing 10 mM NaCl or 10 mM K2B4O7. Samples were visualized by UV shadow or Gel Red (Biotum) staining. Bands corresponding to both G4 DNA and unstructured monomers were excised. Each excised gel fragment was crushed into 25 ml of elution buffer (50 mM Tris–HCl (pH 7.5), 1 mM EDTA, 25 mM NaCl) and was shaken overnight at 4°C. Eluted DNA was syringe-filtered from gel pieces and precipitated by repeated rounds of 2-butanol extraction and standard ethanol precipitation. Purified G4 samples were resuspended in phosphate-buffered saline (PBS) and monomers were resuspended in TE. Both were stored at −20°C. Samples prepared for circular dichroism (CD) analysis were diluted in PBS or TE to a final concentration of 5–10 μM (70–95 μg/ml). CD spectra were measured using a Jasco-810 spectropolarimeter at 25°C. Readings were recorded over a wavelength range of 200–320 nm in a quartz cuvette with a 1-cm path length. Measurements were averaged between three accumulations with an instrument scanning speed of 200 nm/min and readings were blank-corrected with buffer alone. Specificity Antibody specificity was screened by a direct ELISA assay where biotinylated G4 structures were captured by SA-coated plates while double-stranded DNA, single-stranded DNA and various proteins were coated to the plates. Purified antibodies were subsequently added at a half maximal binding concentration and incubated on pre-coated plates for 1 h at room temperature. Bound antibodies were detected using goat anti-mouse HRP and revealed with the ABTS substrate and were quantified by spectrophotometry at 405 nm. Antibody 1H6 underwent another round of specificity testing by competition ELISA. The relative binding specificity by the 1H6 antibody was determined in triplicate measurements by pre-incubation with different competitors at room temperature for 1 h. The 1H6 antibody concentration was below half maximal binding concentration and constant in each competitive reaction. All competing agents were 1000-fold molar excess over 1H6 antibody. Plates coated with immobilized G4-DNA were used to evaluate percentage competition in comparison with incubated antibodies without competitor. A minimum of 4 μg of synthetic DNA or protein was loaded per competition. All competition reactions were incubated in PBS containing 1% BSA and monomeric samples were initially denatured at 95°C for 2 min to maintain single-stranded form. Anti-DNA antibodies were detected with HRP labeled goat anti-mouse IgG and revealed with ABTS substrate. The percentage of competition = [(OD control−OD with competitor)/OD control] × 100. Immunofluorescence microscopy Cells were grown on flamed coverslips in 12-well plates and incubated at 37°C. For some experiments, cells were incubated with TMPyP4 (Calbiochem) or TMS (17) for 24 h before fixation. For proteinase K digestion, cells were pretreated with 10 mg/ml proteinase K for 1 h at 37°C. Cells were fixed in 4% paraformaldehyde (PFA, Alfa Aesar) in PBS and then permeabilized with 0.5% Tween 20 in PBS. Cells were treated with 20 µg/500 µl RNase A (Invitrogen) and subsequently blocked in image-iTFX (Invitrogen) and 5% normal goat serum (Sigma) for 12 h at 4°C. Cells were then incubated with purified G4